Developing a novel class of neuroplasticity-promoting therapeutics
Founded 2019
Partnered 2021
Mark Rus
David Olson
Broadening patient access to safe, fast-acting, and long-lasting medicines for brain disorders including treatment-resistant depression, PTSD, neurodegeneration, and more